THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Clinical trials for THERAPY-RELATED ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new THERAPY-RELATED ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for THERAPY-RELATED ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo aims to stop AML from coming back
Disease control OngoingThis study tests whether a combination of two chemotherapy drugs, azacitidine and venetoclax, can help keep acute myeloid leukemia (AML) from returning in patients who are already in remission. About 50 adults whose leukemia is in first remission but who are not ready for a stem …
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:48 UTC
-
New drug cocktail aims to stop leukemia relapse after transplant
Disease control OngoingThis study tests whether two drugs, venetoclax and azacitidine, can help prevent leukemia from returning in 100 adults who have already had a stem cell transplant. Participants have high-risk acute myeloid leukemia or related blood cancers and are in remission after transplant. T…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:47 UTC
-
New drug cocktail shows promise for tough leukemia in younger patients
Disease control OngoingThis study tests a chemotherapy drug called CPX-351 in people under 60 with secondary acute myeloid leukemia (AML), a type of leukemia that develops after other bone marrow diseases or cancer treatments. The goal is to see how many patients achieve complete remission. 21 particip…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New hope for tough leukemia: drug combo shows promise in early trial
Disease control OngoingThis study tests a new drug called pevonedistat alongside standard chemotherapy for people with a high-risk type of acute myeloid leukemia (AML). The goal is to see if the combination is safe and works better at getting the cancer into remission. About 53 adults with newly diagno…
Matched conditions: THERAPY-RELATED ACUTE MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated May 19, 2026 11:46 UTC